• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长激素和生长抑素基因在伴有活动性肢端肥大症且血浆生长激素轻度升高的垂体腺瘤中的表达

Growth hormone and somatostatin gene expression in pituitary adenomas with active acromegaly and minimal plasma growth hormone elevation.

作者信息

Pagesy P, Li J Y, Rentier-Delrue F, Delalande O, Le Bouc Y, Kujas M, Joubert D, Martial J, Peillon F

机构信息

INSERM U. 223, Faculté de Médecine Pitié-Salpêtrière, Paris, France.

出版信息

Acta Endocrinol (Copenh). 1990 Jun;122(6):745-52. doi: 10.1530/acta.0.1220745.

DOI:10.1530/acta.0.1220745
PMID:1695808
Abstract

Some patients with active acromegaly have elevated plasma IGF-I concentrations with only minimal elevation of plasma GH. We compared adenomatous GH and SRIH expression in 3 such patients (patients No. 1, 2 and 3; basal plasma GH level less than 4 micrograms/l) and in 3 acromegalic patients with high basal plasma GH level (patients No. 4, 5 and 6; 51.7 +/- 16.1 micrograms/l, mean +/- SEM). By immunocytochemistry, all the tumours proved to be somatotropic adenomas. At the ultrastructural level, signs of low secretory activity were observed in adenomas from patients No. 2 and 3. Perifused adenoma cells of patients No. 1, 2 and 3 released very little GH compared with those of patients No. 4, 5 and 6 (1 +/- 0.37 vs 51.5 +/- 34.1 micrograms x (10(-6) cells) x min-1, p less than 0.001). Adenoma SRIH content was 65.7 and 30.6 pg/mg proteins in patients No. 1 and 2, whereas it was undetectable in the others (patients No. 4, 5 and 6). Northern blot analysis showed that the GH gene was poorly expressed in the adenomas from patients No. 1, 2 and 3 compared with the adenomas from patients No. 4, 5 and 6. SRIH mRNA was detected in all 6 adenomas. However, the signal was more intense in the adenomas from patients No. 1, 2 and 3 than in those from patients No. 4, 5 and 6.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

一些患有活动性肢端肥大症的患者血浆胰岛素样生长因子-I(IGF-I)浓度升高,而血浆生长激素(GH)仅有轻微升高。我们比较了3例此类患者(1号、2号和3号患者;基础血浆GH水平低于4微克/升)和3例基础血浆GH水平高的肢端肥大症患者(4号、5号和6号患者;51.7±16.1微克/升,平均值±标准误)腺瘤性GH和生长抑素(SRIH)的表达。通过免疫细胞化学分析,所有肿瘤均为生长激素细胞腺瘤。在超微结构水平上,2号和3号患者的腺瘤中观察到分泌活性低的迹象。与4号、5号和6号患者相比,1号、2号和3号患者的灌流腺瘤细胞释放的GH非常少(1±0.37微克/(10⁻⁶个细胞)×分钟⁻¹ 对51.5±34.1微克/(10⁻⁶个细胞)×分钟⁻¹,p<0.001)。1号和2号患者腺瘤的SRIH含量分别为65.7和30.6皮克/毫克蛋白质,而其他患者(4号、5号和6号患者)未检测到。Northern印迹分析显示,与4号、5号和6号患者的腺瘤相比,1号、2号和3号患者的腺瘤中GH基因表达较差。所有6例腺瘤中均检测到SRIH mRNA。然而,1号、2号和3号患者腺瘤中的信号比4号、5号和6号患者腺瘤中的信号更强。(摘要截短于250字)

相似文献

1
Growth hormone and somatostatin gene expression in pituitary adenomas with active acromegaly and minimal plasma growth hormone elevation.生长激素和生长抑素基因在伴有活动性肢端肥大症且血浆生长激素轻度升高的垂体腺瘤中的表达
Acta Endocrinol (Copenh). 1990 Jun;122(6):745-52. doi: 10.1530/acta.0.1220745.
2
Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients.肢端肥大症患者垂体腺瘤中血浆生长激素对生长抑素(SRIH)及SRIH受体的反应。
J Clin Endocrinol Metab. 1986 Apr;62(4):729-33. doi: 10.1210/jcem-62-4-729.
3
Somatostatin cells in human somatotropic adenomas.人类生长激素腺瘤中的生长抑素细胞。
Virchows Arch A Pathol Anat Histopathol. 1992;420(1):95-101. doi: 10.1007/BF01605990.
4
Effect of vasoactive intestinal polypeptide on growth hormone secretion in perifused acromegalic pituitary adenoma tissues.血管活性肠肽对灌流的肢端肥大症垂体腺瘤组织中生长激素分泌的影响。
J Clin Endocrinol Metab. 1982 Apr;54(4):773-9. doi: 10.1210/jcem-54-4-773.
5
Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.肢端肥大症患者垂体腺瘤中生长激素释放激素受体的特征分析。
J Clin Endocrinol Metab. 1988 Jun;66(6):1265-71. doi: 10.1210/jcem-66-6-1265.
6
Growth hormone-releasing hormone and somatostatin in normal and tumoral human pituitaries.正常及肿瘤性人类垂体中的生长激素释放激素和生长抑素。
Peptides. 1991 Sep-Oct;12(5):945-50. doi: 10.1016/0196-9781(91)90042-n.
7
Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.人生长激素和泌乳素分泌型垂体腺瘤中的生长抑素受体
J Clin Endocrinol Metab. 1985 Jul;61(1):98-103. doi: 10.1210/jcem-61-1-98.
8
The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.促甲状腺激素释放激素受体1信使核糖核酸在人垂体腺瘤中的表达
Clin Endocrinol (Oxf). 2001 Mar;54(3):309-16. doi: 10.1046/j.1365-2265.2001.01237.x.
9
Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.生长激素分泌性腺瘤中的生长抑素受体、腺苷酸环化酶活性及生长激素(GH)对奥曲肽的反应
J Clin Endocrinol Metab. 1993 Dec;77(6):1577-83. doi: 10.1210/jcem.77.6.7903312.
10
Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors.生长激素(GH)释放激素可持续性抑制人GH分泌肿瘤中体外内源性生长抑素的分泌。
J Clin Endocrinol Metab. 1995 May;80(5):1691-5. doi: 10.1210/jcem.80.5.7745020.

引用本文的文献

1
Octreotide Effect on Growth Hormone and Somatostatin Subtype 2 Receptor mRNAs of the Human Pituitary Somatotroph Adenomas.奥曲肽对人垂体生长激素腺瘤生长激素及生长抑素2型受体mRNA的影响
Endocr Pathol. 2000 Spring;11(1):41-48. doi: 10.1385/ep:11:1:41.
2
Morphological characterization and subtyping of silent somatotroph adenomas.无功能生长激素腺瘤的形态学特征及亚型分类
Pituitary. 1999 May;1(3-4):233-41. doi: 10.1023/a:1009942122673.
3
Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior.
生长激素释放激素基因在肢端肥大症相关垂体肿瘤中的过表达。这是一种与肿瘤进展和侵袭性行为相关的事件。
Am J Pathol. 1997 Sep;151(3):769-84.
4
Somatostatin cells in human somatotropic adenomas.人类生长激素腺瘤中的生长抑素细胞。
Virchows Arch A Pathol Anat Histopathol. 1992;420(1):95-101. doi: 10.1007/BF01605990.